# nSTRIDE APS in Females With Primary Patellofemoral Osteoarthritis

> **NCT02610192** · NA · COMPLETED · sponsor: **Zimmer Biomet** · enrollment: 52 (actual)

## Conditions studied

- Patellofemoral Osteoarthritis

## Interventions

- **DEVICE:** nSTRIDE Autologous Protein Solution (APS) Kit

## Key facts

- **NCT ID:** NCT02610192
- **Lead sponsor:** Zimmer Biomet
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2020-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02610192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02610192, "nSTRIDE APS in Females With Primary Patellofemoral Osteoarthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02610192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*